Abstract
The incidence of the population being affected by chronic liver disease is being increased disproportionately, with the expenses of treatment being enormous. With the only effective treatment for end-stage liver disease being liver transplantation, recent growing evidence indicates the potential of cell therapy as a treatment option for different diseases, including liver injury. Human Amniotic Epithelial Cells (hAECs) are isolated from the amnion of the placenta in sufficient numbers for clinical use and bear many characteristics of traditional stem cells. The work performed in the thesis adds to the evidence that hAECs may be used as a potential therapy for liver injury.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
